ORG-26576
id:
org-26576-201-1437418
title:
ORG-26576
text:
ORG-26576 is an ampakine originally developed by Cortex Pharmaceuticals and then licensed to Organon International for development. In animal studies it has been shown to effectively potentiate AMPA receptor function, leading to increased BDNF release and enhanced neuronal differentiation and survival, as well as producing nootropic effects in standardised assays. Development as an antidepressant has been halted due to a failed Phase II trial for major depressive disorder.
brand slug:
wiki
category slug:
encyclopedia
description:
Ampakine
original url:
https://en.wikipedia.org/wiki/ORG-26576
date created:
date modified:
2024-01-28T02:57:56Z
main entity:
{"identifier":"Q5642889","url":"https://www.wikidata.org/entity/Q5642889"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c6/Org_26576.svg","width":1069,"height":826}
fields total:
13
integrity:
15